17 April 2025 Companies Announcements Office Australian Securities Exchange Notification of Quarterly Results / Investor Conference Call ImpediMed Limited (ASX: IPD) advises it will release its Appendix 4C Quarterly Cash Flow Report for the period ending 31 March 2025 on Wednesday 30 April 2025. Investors are invited to join a conference call hosted by CEO and Managing Director Dr Parmjot Bains and CF&OO and Executive Director McGregor Grant at 9.00 am AEST on Wednesday 30 April 2025. A question and answer session will follow a management presentation. Investors can ask questions live or send questions in advance of the call to [email protected]. To pre-register, please follow this link https://s1.c-conf.com/diamondpass/10046906-93iwce.html. Registered participants will receive a calendar notification with dial in details and a PIN for fast-track access to the call. Authorised for release to the ASX by Leanne Ralph, Company Secretary.
IPD Price at posting:
3.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)